ReviewCurrent oncology reports2025

Investigating the Latest Evidence from Phase III Trials Supporting Treatment Options for De novo Clinically Lymph Node-Positive Hormone-Sensitive Prostate Cancer.

Mohamed Ibrahim Elewaily et al.PubMed ↗Publisher ↗

No numbers read from the abstract.